Analystreport

Pacira Pharmaceuticals Inc (NASDAQ: PCRX) is now covered by analysts at Stifel Nicolaus. They set a "sell" rating on the stock.

Pacira BioSciences, Inc.  (PCRX) 
Last pacira biosciences, inc. earnings: 2/20 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investor.pacira.com